Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3869 | YDES YD Bio Limited - Ordinary Shares | 2.00 USD | 0.00% | -17.36% | -32.20% | -75.00% | 141.58 M USD | ||
| 3874 | CBUS Cibus, Inc. - Class A Common Stock | 1.76 USD | +17.33% | +24.82% | +43.09% | +10.00% | 134.34 M USD | ||
| 3885 | CUE Cue Biopharma, Inc. - Common Stock | 32.66 USD | -2.19% | +11.66% | +11.20% | +4313.51% | 132.13 M USD | ||
| 3891 | ENGN enGene Therapeutics Inc. - Common Stock | 1.85 USD | -3.65% | +4.52% | +10.78% | -77.98% | 123.93 M USD | ||
| 3894 | GNLX Genelux Corporation - Common Stock | 2.87 USD | -3.37% | -0.35% | -4.01% | -17.77% | 128.69 M USD | ||
| 3895 | ALDX Aldeyra Therapeutics, Inc. - Common Stock | 2.13 USD | -4.48% | -9.75% | +21.02% | -51.59% | 128.48 M USD | ||
| 3900 | COYA Coya Therapeutics, Inc. - Common Stock | 5.38 USD | -6.43% | -8.03% | +15.95% | -12.66% | 126.20 M USD | ||
| 3903 | VANI Vivani Medical, Inc. - Common Stock | 1.50 USD | +11.11% | +22.95% | +30.43% | +18.11% | 129.35 M USD | ||
| 3909 | GUTS Fractyl Health, Inc. - Common Stock | 0.78 USD | -2.50% | -2.50% | +16.42% | -48.68% | 123.75 M USD | ||
| 3911 | SPRO Spero Therapeutics, Inc. - Common Stock | 2.13 USD | -1.39% | -5.33% | -23.38% | -28.28% | 123.33 M USD | ||
| 3915 | PMN ProMIS Neurosciences Inc. - Common Shares | 13.65 USD | +0.74% | +0.59% | +35.82% | +3312.50% | 122.41 M USD | ||
| 3928 | SEER Seer, Inc. - Class A Common Stock | 2.18 USD | -1.80% | +28.99% | +21.79% | 0.00% | 119.86 M USD | ||
| 3938 | AARD Aardvark Therapeutics, Inc. - Common Stock | 5.09 USD | -6.43% | -6.26% | +42.18% | -59.64% | 111.05 M USD | ||
| 3944 | KLRS Kalaris Therapeutics, Inc. - Common Stock | 4.53 USD | -6.21% | +0.67% | +6.34% | -55.72% | 107.78 M USD | ||
| 3951 | NTHI NeOnc Technologies Holdings, Inc. - Common Stock | 4.31 USD | -0.92% | -1.60% | -5.27% | -50.86% | 112.12 M USD | ||
| 3953 | VRCA Verrica Pharmaceuticals Inc. - Common Stock | 6.35 USD | +4.61% | +7.26% | +5.31% | +5.48% | 109.09 M USD | ||
| 3961 | BDTX Black Diamond Therapeutics, Inc. - Common Stock | 1.91 USD | -8.17% | -1.04% | +1.06% | -23.60% | 109.45 M USD | ||
| 3983 | ENLV Enlivex Ltd. - Ordinary Shares | 0.44 USD | -10.20% | -20.00% | -38.89% | -63.33% | 104.45 M USD | ||
| 3988 | ANIX Anixa Biosciences, Inc. - Common Stock | 3.12 USD | +5.41% | +6.85% | +26.83% | -0.64% | 106.15 M USD | ||
| 3994 | ONCY Oncolytics Biotech Inc. - Common Stock | 0.84 USD | -2.33% | -11.58% | -1.18% | -35.38% | 100.26 M USD |
Nouvelles Biotechnology Stocks
Seres Therapeutics publie des données préliminaires sur les complications de la thérapie contre le cancer | Benzinga France
TD Cowen réitère son avis d’achat sur Prime Medicine après une victoire en arbitrage
BofA maintient sa recommandation sur Beam Therapeutics après la décision arbitrale
Pourquoi l’action Beam Therapeutics chute-t-elle aujourd’hui ?
Pourquoi l’action Prime Medicine s’envole-t-elle aujourd’hui ?
L’action Incyte atteint un plus haut de 52 semaines à 118,77 $
L’action Prime Medicine bondit après une victoire en arbitrage contre Beam
Gainers Biotechnology Stocks
TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
Losers Biotechnology Stocks
CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |
ONCO Onconetix, Inc. - Common Stock | 0.95 | -11.21% |